European Journal of Surgical Oncology
Volume 34, Issue 2 , Pages 149-153 , February 2008

A comparative study of risk factors and prognostic features between symptomatic and screen detected breast cancer

  • J.P. Burke

      Affiliations

    • Department of Surgery, Mater Misericordiae University Hospital, Eccles Street, Dublin 7, Ireland
  • ,
  • C. Power

      Affiliations

    • Department of Surgery, Mater Misericordiae University Hospital, Eccles Street, Dublin 7, Ireland
  • ,
  • T.F. Gorey

      Affiliations

    • Department of Surgery, Mater Misericordiae University Hospital, Eccles Street, Dublin 7, Ireland
    • Eccles Breast Screening Unit, Mater Misericordiae University Hospital, Eccles Street, Dublin 7, Ireland
  • ,
  • F. Flanagan

      Affiliations

    • Department of Radiology, Mater Misericordiae University Hospital, Eccles Street, Dublin 7, Ireland
    • Eccles Breast Screening Unit, Mater Misericordiae University Hospital, Eccles Street, Dublin 7, Ireland
  • ,
  • M.J. Kerin

      Affiliations

    • Eccles Breast Screening Unit, Mater Misericordiae University Hospital, Eccles Street, Dublin 7, Ireland
    • Clinical Science Institute, University College Hospital, Galway, Ireland
  • ,
  • M.R. Kell

      Affiliations

    • Department of Surgery, Mater Misericordiae University Hospital, Eccles Street, Dublin 7, Ireland
    • Eccles Breast Screening Unit, Mater Misericordiae University Hospital, Eccles Street, Dublin 7, Ireland
    • Corresponding Author InformationCorresponding author. Eccles Breast Screening Unit, Mater Misericordiae University Hospital, Eccles Street, Dublin 7, Ireland. Tel.: +353 1 882 6200; fax: +353 1 882 6225.

,Accepted 27 March 2007.

References 

  1. Berry DA, Cronin KA, Plevritis SK, et al. Effect of screening and adjuvant therapy on mortality from breast cancer. N Engl J Med. 2005;353(17):1784–1792
  2. Olsen AH, Njor SH, Vejborg I, et al. Breast cancer mortality in Copenhagen after introduction of mammography screening: cohort study. BMJ. 2005;330(7485):220
  3. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet. 2005;365(9472):1687–1717
  4. Blanks RG, Moss SM, McGahan CE, et al. Effect of NHS breast screening programme on mortality from breast cancer in England and Wales, 1990–8: comparison of observed with predicted mortality. BMJ. 2000;321(7262):665–669
  5. Gotzsche PC, Nielsen M. Screening for breast cancer with mammography. Cochrane Database Syst Rev. 2006 Oct 18;(4):CD001877
  6. Goodman SN. The mammography dilemma: a crisis for evidence-based medicine?. Ann Intern Med. 2002;137(5 Part 1):363–365
  7. Zahl PH, Andersen JM, Maehlen J. Spontaneous regression of cancerous tumors detected by mammography screening. JAMA. 2004;292(21):2579–2580
  8. Cancer IAFRO . Breast cancer screening. IARC handbooks of cancer prevention. Lyon, France: IARC Press; 2002;
  9. Duffy SW. Some current issues in breast cancer screening. J Med Screen. 2005;12:128–133
  10. Zahl PH, Strand BH, Maehlen J. Incidence of breast cancer in Norway and Sweden during introduction of nationwide screening: prospective cohort study. BMJ. 2004;328(7445):921–924
  11. Olsen O, Gotzsche PC. Cochrane review on screening for breast cancer with mammography. Lancet. 2001;358(9290):1340–1342
  12. Joensuu H, Lehtimaki T, Holli K, et al. Risk for distant recurrence of breast cancer detected by mammography screening or other methods. JAMA. 2004;292(9):1064–1073
  13. Gail MH, Brinton LA, Byar DP, et al. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst. 1989;81(24):1879–1886
  14. Todd JH, Dowle C, Williams MR, et al. Confirmation of a prognostic index in primary breast cancer. Br J Cancer. 1987;56(4):489–492
  15. Chen CL, Weiss NS, Newcomb P, et al. Hormone replacement therapy in relation to breast cancer. JAMA. 2002;287(6):734–741
  16. Pappo I, Meirshon I, Karni T, et al. The characteristics of malignant breast tumors in hormone replacement therapy users versus nonusers. Ann Surg Oncol. 2004;11(1):52–58
  17. Kumar AS, Cureton E, Shim V, et al. Type and duration of exogenous hormone use affects breast cancer histology. Ann Surg Oncol. 2007 Feb;14(2):695–703
  18. Moody-Ayers SY, Wells CK, Feinstein AR. “Benign” tumors and “early detection” in mammography-screened patients of a natural cohort with breast cancer. Arch Intern Med. 2000;160(8):1109–1115
  19. Porter PL, El-Bastawissi AY, Mandelson MT, et al. Breast tumor characteristics as predictors of mammographic detection: comparison of interval- and screen-detected cancers. J Natl Cancer Inst. 1999;91(23):2020–2028
  20. Purushotham AD, Macmillan RD, Wishart GC. Advances in axillary surgery for breast cancer-time for a tailored approach. Eur J Surg Oncol. 2005;31(9):929–931
  21. Dillon MF, Hill AD, Quinn CM, et al. Surgical intervention in screen-detected patients versus symptomatic patients with breast cancer. J Med Screen. 2004;11(3):130–134
  22. Bucchi L, Barchielli A, Ravaioli A, et al. Screen-detected vs clinical breast cancer: the advantage in the relative risk of lymph node metastases decreases with increasing tumour size. Br J Cancer. 2005;92(1):156–161
  23. Moller H, Davies E. Over-diagnosis in breast cancer screening. BMJ. 2006;332(7543):691–692
  24. Nielsen M, Thomsen JL, Primdahl S, et al. Breast cancer and atypia among young and middle-aged women: a study of 110 medicolegal autopsies. Br J Cancer. 1987;56(6):814–819
  25. Holford TR, Roush GC, McKay LA. Trends in female breast cancer in Connecticut and the United States. J Clin Epidemiol. 1991;44(1):29–39
  26. Welch HG, Black WC. Using autopsy series to estimate the disease “reservoir” for ductal carcinoma in situ of the breast: how much more breast cancer can we find?. Ann Intern Med. 1997;127(11):1023–1028

PII: S0748-7983(07)00152-7

doi: 10.1016/j.ejso.2007.03.025

European Journal of Surgical Oncology
Volume 34, Issue 2 , Pages 149-153 , February 2008